MCP
EW icon

Militia Capital Partners’s Edwards Lifesciences EW Stock Holding History

Militia Capital Partners’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,000
Closed -$782K – 193
2025
Q2 		$782K Hold
10,000
– – 0.36% 76
2025
Q1 		$725K Hold
10,000
– – 0.58% 49
2024
Q4 		$740K Buy
+10,000
New +$700K 0.66% 36

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Militia Capital Partners's EW Position: Q3 2025 in Review

Militia Capital Partners sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 10,000 shares — an estimated $782K sold.

Militia Capital Partners first reported a position in EW in Q4 2024 and held it in 3 quarters. The position peaked at $782K in Q2 2025. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Militia Capital Partners reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
  • Militia Capital Partners sold 10,000 Edwards Lifesciences shares in Q3 2025, an estimated $782K.
  • Militia Capital Partners first reported a position in Edwards Lifesciences in Q4 2024 and held it in 3 quarters.
  • Militia Capital Partners's Edwards Lifesciences position peaked at $782K in Q2 2025.
  • 1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Militia Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.